Thus, the relationship between TGFBI overexpression and worse outcome appears plausible and could indicate that AREG and TGFBI and its relationship to EGFR might be a reasonable approach in therapy of HPV-associated HNSCC. This evidence concerns the gene TGFBI and head and neck squamous cell carcinoma.